Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2024 Filed Feb 6, 2024 18:34 UTC |
RUTHERFORD BILL BCFO and EVP
|
GiftCommon Stock | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002937 · doc4.xml · nonDerivative · entry 3 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,642 Read SEC document |
| February 05, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
SaleCommon Stock | 1,645 | $312.00 | $513,240.00 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · nonDerivative · entry 8 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,646 Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:45 UTC |
Wyatt Christopher F.SVP & Controller
|
SaleCommon Stock | 4,000 | $312.42 | $1,249,680.00 |
DisclosureSEC source: 0001209191-24-002971 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,383 Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:45 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 2,000 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-24-002970 · doc4.xml · derivative · entry 7 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,040 Underlying: Common Stock · 2,000 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:45 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 4,040 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-24-002970 · doc4.xml · derivative · entry 6 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,040 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:45 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 2,510 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-24-002970 · doc4.xml · derivative · entry 5 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,510 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:45 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Tax withholdingCommon Stock | 4,288 | $310.62 | $1,331,938.56 |
DisclosureSEC source: 0001209191-24-002970 · doc4.xml · nonDerivative · entry 4 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,512 Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:45 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionCommon Stock | 2,000 | $101.16 | $202,320.00 |
DisclosureSEC source: 0001209191-24-002970 · doc4.xml · nonDerivative · entry 3 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:45 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionCommon Stock | 4,040 | $81.96 | $331,118.40 |
DisclosureSEC source: 0001209191-24-002970 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:45 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Exercise / conversionCommon Stock | 2,510 | $69.58 | $174,645.80 |
DisclosureSEC source: 0001209191-24-002970 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionRestricted Stock Units · Derivative | 137 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · derivative · entry 13 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138 Underlying: Common Stock · 137 shares Expires 2031-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning February 3, 2022. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Tax withholdingCommon Stock | 34 | $309.42 | $10,520.28 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · nonDerivative · entry 7 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,291 Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionCommon Stock | 137 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · nonDerivative · entry 6 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:28 UTC |
Wasserman Chad JSVP and CIO
|
Exercise / conversionRestricted Stock Units · Derivative | 127 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002935 · doc4.xml · derivative · entry 4 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128 Underlying: Common Stock · 127 shares Expires 2031-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest in two equal annual installments beginning February 3, 2024. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:28 UTC |
Wasserman Chad JSVP and CIO
|
Tax withholdingCommon Stock | 38 | $309.42 | $11,757.96 |
DisclosureSEC source: 0001209191-24-002935 · doc4.xml · nonDerivative · entry 3 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379.3102 F2 · balance_after: Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 03, 2024 Filed Feb 6, 2024 18:28 UTC |
Wasserman Chad JSVP and CIO
|
Exercise / conversionCommon Stock | 127 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002935 · doc4.xml · nonDerivative · entry 2 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417.3102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert into common stock on a one-for-one basis. F2 · balance_after: Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:34 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionStock Appreciation Right · Derivative | 19,100 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-24-002937 · doc4.xml · derivative · entry 10 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,100 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:34 UTC |
RUTHERFORD BILL BCFO and EVP
|
Tax withholdingCommon Stock | 9,652 | $309.42 | $2,986,521.84 |
DisclosureSEC source: 0001209191-24-002937 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,817 Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:34 UTC |
RUTHERFORD BILL BCFO and EVP
|
Exercise / conversionCommon Stock | 19,100 | $69.58 | $1,328,978.00 |
DisclosureSEC source: 0001209191-24-002937 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionStock Appreciation Right · Derivative | 1,263 | $0.00 Strike: $253.30 | $0.00 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · derivative · entry 12 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,789 Underlying: Common Stock · 1,263 shares Expires 2033-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionStock Appreciation Right · Derivative | 2,775 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · derivative · entry 11 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2032-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionStock Appreciation Right · Derivative | 1,340 | $0.00 Strike: $241.81 | $0.00 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · derivative · entry 10 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,340 Underlying: Common Stock · 1,340 shares Expires 2031-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on October 25, 2022. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionStock Appreciation Right · Derivative | 920 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · derivative · entry 9 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 920 Underlying: Common Stock · 920 shares Expires 2031-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Tax withholdingCommon Stock | 5,127 | $309.42 | $1,586,396.34 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · nonDerivative · entry 5 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,188 Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionCommon Stock | 1,263 | $253.30 | $319,917.90 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · nonDerivative · entry 4 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionCommon Stock | 2,775 | $236.61 | $656,592.75 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · nonDerivative · entry 3 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionCommon Stock | 1,340 | $241.81 | $324,025.40 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · nonDerivative · entry 2 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:29 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionCommon Stock | 920 | $173.12 | $159,270.40 |
DisclosureSEC source: 0001209191-24-002936 · doc4.xml · nonDerivative · entry 1 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 18:28 UTC |
Wasserman Chad JSVP and CIO
|
SaleCommon Stock | 652 | $312.04 | $203,450.54 |
DisclosureSEC source: 0001209191-24-002935 · doc4.xml · nonDerivative · entry 1 Wasserman Chad J · CIK 0002010252 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290.3102 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.0111 to $312.06, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 1,263 | $0.00 Strike: $253.30 | $0.00 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · derivative · entry 11 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,789 Underlying: Common Stock · 1,263 shares Expires 2033-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 2,775 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · derivative · entry 10 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775 Underlying: Common Stock · 2,775 shares Expires 2032-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 4,185 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · derivative · entry 9 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,185 Underlying: Common Stock · 4,185 shares Expires 2031-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 4,771 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · derivative · entry 8 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,771 shares Expires 2030-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Tax withholdingCommon Stock | 9,268 | $314.66 | $2,916,268.88 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · nonDerivative · entry 6 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,625 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 1,263 | $253.30 | $319,917.90 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · nonDerivative · entry 5 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 2,775 | $236.61 | $656,592.75 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · nonDerivative · entry 4 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 4,185 | $173.12 | $724,507.20 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · nonDerivative · entry 3 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 4,771 | $145.24 | $692,940.04 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC |
Wyatt Christopher F.SVP & Controller
|
GrantStock Appreciation Right · Derivative | 4,402 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · derivative · entry 6 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,402 Underlying: Common Stock · 4,402 shares Expires 2034-01-31 F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionStock Appreciation Right · Derivative | 9,000 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · derivative · entry 5 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 9,000 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionStock Appreciation Right · Derivative | 2,680 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · derivative · entry 4 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,680 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC |
Wyatt Christopher F.SVP & Controller
|
Tax withholdingCommon Stock | 6,376 | $304.90 | $1,944,042.40 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · nonDerivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,383 Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionCommon Stock | 9,000 | $101.16 | $910,440.00 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionCommon Stock | 2,680 | $81.96 | $219,652.80 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:52 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
GrantStock Appreciation Right · Derivative | 3,302 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002733 · doc4.xml · derivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,302 Underlying: Common Stock · 3,302 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
GrantStock Appreciation Right · Derivative | 4,402 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · derivative · entry 7 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,402 Underlying: Common Stock · 4,402 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:51 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 3,861 | $307.00 | $1,185,327.00 |
DisclosureSEC source: 0001209191-24-002732 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,899 Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:50 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GrantStock Appreciation Right · Derivative | 4,402 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002731 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,402 Underlying: Common Stock · 4,402 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:49 UTC |
RUTHERFORD BILL BCFO and EVP
|
GrantStock Appreciation Right · Derivative | 20,634 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002730 · doc4.xml · derivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,634 Underlying: Common Stock · 20,634 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:48 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
GrantStock Appreciation Right · Derivative | 4,402 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002729 · doc4.xml · derivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,402 Underlying: Common Stock · 4,402 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.